首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo
【24h】

Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo

机译:鉴定在体外和体内竞争性抑制钙调神经磷酸酶活性的DSCR1肽片段

获取原文
获取原文并翻译 | 示例
       

摘要

Calcineurin phosphatase activity regulates the nuclear localization of the nuclear factor of activated T cells (NFAT) family of transcription factors during immune challenge. Calcineurin inhibitors, such as the cyclosporin A-cyclophilin A and FK506-FKBP12 complexes, regulate this enzymatic activity noncompetitively by binding at a site distinct from the enzyme active site. A family of endogenous protein inhibitors of calcineurin was recently identified and shown to block calcineurin-mediated NFAT nuclear localization and transcriptional activation. One such inhibitor, Down Syndrome Critical Region 1 (DSCR1), functions in T cell activation, cardiac hypertrophy, and angiogenesis. We have identified a small region of DSCR1 that is a potent inhibitor of calcineurin activity in vitro and in vivo.
机译:钙调神经磷酸酶活性调节免疫攻击过程中转录因子的活化T细胞(NFAT)家族的核因子的核定位。钙调神经磷酸酶抑制剂,例如环孢菌素A-亲环蛋白A和FK506-FKBP12复合物,通过与酶活性位点不同的位点结合,非竞争性地调节该酶活性。最近发现了钙调神经磷酸酶的内源性蛋白抑制剂家族,并显示它们可以阻止钙调神经磷酸酶介导的NFAT核定位和转录激活。一种这样的抑制剂,唐氏综合症关键区1(DSCR1),在T细胞活化,心脏肥大和血管生成中起作用。我们已经确定了DSCR1的一个小区域,它是体外和体内钙调神经磷酸酶活性的有效抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号